Alabaster (Diagnostic Equipment) Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Alabaster (Diagnostic Equipment) General Information

Description

Developer of medical devices designed to decrease the risk of infection. The company's devices and equipment are used for biopsy procedures to decrease the risk of infection and improve efficiency, enabling patients to begin treatment quickly and result in an advanced likelihood of a successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Vancouver, British Columbia
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alabaster (Diagnostic Equipment) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2016 Completed Startup
To view Alabaster (Diagnostic Equipment)’s complete valuation and funding history, request access »

Alabaster (Diagnostic Equipment) Patents

Alabaster (Diagnostic Equipment) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2996350-A1 Therapeutic agent delivering biopsy needle device and method of use Abandoned 25-Aug-2015 0000000000
US-20170055901-A1 Therapeutic agent delivering biopsy needle device and method of use Abandoned 25-Aug-2015 0000000000

Alabaster (Diagnostic Equipment) Board Members (1)

Name Representing Role Since
Douglas Janzen NorthView Lifesciences Board Member 000 0000
To view Alabaster (Diagnostic Equipment)’s complete board members history, request access »

Alabaster (Diagnostic Equipment) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NorthView Lifesciences Venture Capital Minority 000 0000 000000 0
To view Alabaster (Diagnostic Equipment)’s complete investors history, request access »